Learn how smiling — and mimicking other people’s smiles — can make you seem more trustworthy and confident.
DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...
The combination of trabectedin (Yondelis; Pharma Mar, Johnson & Johnson) and olaparib (Lynparza; AstraZeneca, Merck) may be a meaningful treatment for certain patients with advanced soft tissue ...
Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback